Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19)
- PMID: 33620107
- PMCID: PMC8013491
- DOI: 10.1002/jmv.26898
Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19)
Conflict of interest statement
Carlo Pallotto has received funds for speaking at symposia organized on behalf of Merck, Angelini, and Bristol Myers Squibb.
Comment in
-
Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.J Med Virol. 2021 Oct;93(10):5724-5725. doi: 10.1002/jmv.27177. Epub 2021 Jul 14. J Med Virol. 2021. PMID: 34232520 Free PMC article. No abstract available.
References
-
- WHO . Coronavirus Disease 2019 (COVID‐19). Weekly Epidemiological Update, October 5th, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
-
- Pallotto C, Suardi LR, Esperti S, et al. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID‐19): a retrospective multicentre study. Infect Dis (Lond). 2020;52:675‐677. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources